Literature DB >> 18795700

Splenectomy improves liver function in patients with liver cirrhosis.

Kazumoto Murata1, Keiichi Ito, Kentaro Yoneda, Katsuya Shiraki, Hiroyuki Sakurai, Msaaki Ito.   

Abstract

BACKGROUND/AIMS: Partial splenic embolization or splenectomy has been reported to improve liver function as well as hypersplenism. The aim of this study was to evaluate the effects of splenectomy in patients with liver cirrhosis (LC) on liver function.
METHODOLOGY: Twelve consecutive patients with LC were followed for more than 6 months using laboratory examinations, ultrasonography (US) and computed tomography. Portal blood flow was measured using color Doppler US before and after splenectomy in 6 cases.
RESULTS: Hypersplenism was improved in all patients. Protein synthesis in the liver was improved, which significantly correlated with these patients' increased liver volume. Having a large spleen and a low serum alanine aminotransferase (ALT) levels are predictive factors for favorable improvement of liver function after splenectomy. Splenectomy was safely carried out in all patients without major complications except for portal thrombus occurred in 4 patients, but did not affect liver function if it was well treated.
CONCLUSIONS: Splenectomy improved liver function in patients with LC, and could be a supportive and bridging therapy for patients waiting for liver transplantation, especially with large spleen and lower ALT levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18795700

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  12 in total

1.  Traumatic splenectomy in a cirrhotic patient with hepatitis C and alcoholic liver disease.

Authors:  Hosam E Matar; Ashraf S Elmetwally; Manojkumar S Nair; Rudi Borgstein; Olu Oluwajobi
Journal:  BMJ Case Rep       Date:  2012-01-03

2.  Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice.

Authors:  Kazutaka Tanabe; Kojiro Taura; Yukinori Koyama; Gen Yamamoto; Takahiro Nishio; Yukihiro Okuda; Kojiro Nakamura; Kan Toriguchi; Kenji Takemoto; Kenya Yamanaka; Keiko Iwaisako; Satoru Seo; Masataka Asagiri; Etsuro Hatano; Shinji Uemoto
Journal:  J Gastroenterol       Date:  2015-02-28       Impact factor: 7.527

3.  Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Authors:  Kazuki Takeishi; Hirofumi Kawanaka; Shinji Itoh; Norifumi Harimoto; Toru Ikegami; Tomoharu Yoshizumi; Ken Shirabe; Yoshihiko Maehara
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

Review 4.  The spleen in liver cirrhosis: revisiting an old enemy with novel targets.

Authors:  Liang Li; Mubing Duan; Weisan Chen; An Jiang; Xiaoming Li; Jun Yang; Zongfang Li
Journal:  J Transl Med       Date:  2017-05-23       Impact factor: 5.531

5.  Splenectomy Promotes Macrophage Polarization in a Mouse Model of Concanavalin A- (ConA-) Induced Liver Fibrosis.

Authors:  Yongjuan Wang; Xiaopei Guo; Guohui Jiao; Lili Luo; Lu Zhou; Jie Zhang; Bangmao Wang
Journal:  Biomed Res Int       Date:  2019-01-06       Impact factor: 3.411

6.  Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma.

Authors:  Hyun Seok Lee; Soo Young Park; Sung Kook Kim; Young Oh Kweon; Won Young Tak; Chang Min Cho; Seong Woo Jeon; Min Kyu Jung; Hyun Gu Park; Dong Wook Lee; So Young Choi
Journal:  Clin Mol Hepatol       Date:  2012-09-25

7.  Effect of antiviral therapy on the survival and incidence of major complications in HBV-associated cirrhotic patients after splenectomy for hypersplenism and portal hypertension.

Authors:  Ningqiang Tian; Zhengwen Liu; Mingbo Yang; Zhu Li; Guoyu Zhang; Qunying Han; Na Li; Qianqian Zhu; Yi Lv; Yawen Wang; Fanfan Xing
Journal:  Virol J       Date:  2012-11-16       Impact factor: 4.099

Review 8.  Platelets in liver disease, cancer and regeneration.

Authors:  Tomohiro Kurokawa; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

9.  Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt.

Authors:  Ahmed Nagaty; Ekram W Abd El-Wahab
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

10.  Improved survival following splenectomy combined with curative treatments for hepatocellular carcinoma in Child B patients: A propensity score matching study.

Authors:  Youliang Pei; Zhanguo Zhang; Abdoul-Aziz Mba'nbo-Koumpa; Xiaoping Chen; Wanguang Zhang
Journal:  Hepatol Res       Date:  2019-01-04       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.